News - Advanced Viral Research
2008-10-30 09:00:41
Advanced Viral Research, a biopharmaceutical company, has started a Phase IIb efficacy study for AVR123 in wound healing.
Advanced Viral Research, a biopharmaceutical company, has started a Phase IIb efficacy study for AVR123 in wound healing.